Diagnosis: Toxoplasmosis with Ring-Enhancing Brain Lesions

脑炎 弓形虫病 弓形虫 医学 免疫学 病理 儿科 病毒学 病毒 抗体
作者
Jennifer L. Wiler
出处
期刊:Emergency medicine news [Lippincott Williams & Wilkins]
卷期号:28 (8): 19-19 被引量:2
标识
DOI:10.1097/00132981-200608000-00030
摘要

Toxoplasma gondii is an obligate intracellular parasite that causes toxoplasmosis. The parasite is ubiquitous, with more than 60 million people in the United States likely infected. (Centers for Disease Control and Prevention, www.cdc.gov/ncidod/dpd/parasites/toxoplasmosis/factsht_toxoplasmosis.htm, accessed May 2006.) Infection can occur by ingestion of parasitic oocysts following handling contaminated soil or cat litter, receiving an infected organ transplant or blood transfusion (rare), or the consumption of contaminated water or food (unwashed garden vegetables). The parasite is rarely of clinical significance in an immunocompetent host. Immunocompromised individuals, newborns, and fetuses (transmission of the tachyzoite form to the fetus can occur via the placenta following primary maternal infection), however, are at high risk for severe or life-threatening disease from toxoplasmosis. T. gondii has been shown to cause chorioretinitis, myocarditis, pneumonitis, and congenital disease. Toxoplasma encephalitis (Toxo encephalitis) is the most common cause of focal encephalitis in patients with AIDS. Toxo encephalitis results from reactivation of chronic latent infection in more than 95 percent of patients. Patients with Toxo encephalitis have single or multiple brain abscesses so their presentation is not specific for Toxo encephalitis. Patients may present with headache, confusion, fever, altered mental status, and neurologic deficits. The typical presentation is a subacute onset with focal neurologic abnormalities in 58 percent to 89 percent of patients. In 15 percent to 30 percent of cases, the clinical presentation may be more abrupt, with seizures or cerebral hemorrhage. Head CT scans in AIDS patients who have Toxo encephalitis reveal multiple ring-enhancing lesions in 70 percent to 80 percent of cases. The thin-walled cavitating lesions with contrast enhancement and surrounding edema often are found in the basal ganglia (approximately 75% cases) or the gray-white matter junction. Magnetic resonance imaging also can be useful for further characterization of the lesions because of its superior sensitivity. Multiple laboratory diagnostic tests are available to diagnose Toxo encephalitis. These include isolation of T. gondii from infected body tissue or fluid by enzyme-linked immunosorbent assay (ELISA) technique, indirect fluorescent antibody, polymerase chain reaction, or hemagglutination testing. Serological tests usually are not helpful because the antibody to T. gondii is so prevalent. If serum tests are negative for T. gondii, an alternative diagnosis should be sought. Cerebrospinal fluid evaluation may be helpful in the diagnostic evaluation of Toxo encephalitis, including differentiation between Toxo, progressive multifocal leukoencephalopathy caused by the JC virus, lymphoma, cytomegalovirus (CMV), or other infectious etiologies. Lumbar puncture is contraindicated if the patient has lesions producing mass-effect or focal signs because of the risk of brain herniation.FigureFigureThe current standard of care allows treatment of Toxo encephalitis to be initiated with a presumptive diagnosis based on the presence of characteristic neuroradiographic findings (e.g., multiple contrast enhancing mass lesions on CT or MRI), findings of clinical neurologic dysfunction, and clinical suspicion of AIDS. Brain toxoplasmosis is considered an AIDS-defining illness with a CD4 less than 100 cells/uL in most cases. This diagnosis should prompt further pertinent evaluations including HIV testing. The differential diagnosis of ring-enhancing lesions on head CT scan is extensive, including metastatic disease, demyelinating disease, infection/septic emboli, post-radiation changes, resolving hematoma, and infarction. In patients with advanced AIDS who have CNS findings, physicians must consider, in addition to common bacterial causes of encephalitis, Toxo encephalitis (50% of all brain lesions in AIDS patients), primary CNS lymphoma associated with Epstein-Barr virus (30% of all brain lesions in AIDS patients), progressive multifocal leukoencephalopathy (JC virus), HIV encephalopathy (HIV), CMV encephalitis (CMV), tuberculosis, cryptococcus, histoplasmosis, candidiasis, coccidioidomycosis, aspergillosis, trypanosomiasis, herpetic meningoencephalitis, neurocysticercosis, meningovascular syphilis, and amoebic abscesses. The standard treatment of choice for Toxo encephalitis is a combination of pyrimethamine, sulfadiazine, and leucovorin (folinic acid) to reduce hematologic toxicity. This treatment regimen is generally reserved for immunocompromised patients with acute infection, reactivation of chronic infection, or patients with congenital infection. Pyrimethamine (Daraprim) is a folic acid antagonist that selectively inhibits plasmodial dihydrofolate reductase. It is highly selective against plasmodia and T gondii, and is a Category C medication. Primary therapy should be given for at least six weeks. Although most patients respond to Toxo encephalitis treatment (60% to 90%), the long-term prognosis is guarded because the risk of death from dementia may be increased. (Inf Dis 2006; 12[2]:111.) Anticonvulsants should be given to those patients who seize, and steroids should be considered for all patients with clinically significant brain edema. Chronic suppressive therapy may be indicated after initial treatment. For patients with a CD4 T-cell count less than 100 cells/uL and positive Toxo serology, oral TMP-SMX is recommended for prophylaxis. Patients who are HIV-positive should begin antiretroviral therapy. All patients with clinically significant Toxo encephalitis require admission and antiparasitic therapy. With appropriate pharmacological therapy, patients should show clinical improvement in two to three weeks, or an alternative diagnosis should be sought. Our patient was found to have an absolute CD4 T-cell count of 29. Cerebrospinal fluid revealed an elevated total protein of 53 mg/dL, a red blood count of 285 /uL, and a white blood count of 35 /uL with 16% segmented neutrophils and 81% lymphocytes. He was presumptively diagnosed with Toxo encephalitis, and discharged home on hospital day three on the appropriate medical regimen with appointments for appropriate follow-up.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HYH完成签到,获得积分10
刚刚
好吃懒做发布了新的文献求助10
2秒前
zkkdsg发布了新的文献求助10
2秒前
风趣青槐完成签到,获得积分10
2秒前
meta完成签到,获得积分20
3秒前
连宛白完成签到,获得积分10
3秒前
wangzh发布了新的文献求助10
3秒前
岳普完成签到,获得积分10
3秒前
余香的应助被KJ采纳,获得10
3秒前
LinqiangQuan发布了新的文献求助10
4秒前
长安心动明月完成签到,获得积分10
5秒前
dfuggh发布了新的文献求助10
5秒前
琪琪发布了新的文献求助10
6秒前
水煮电吹风的应助被小鱼采纳,获得10
6秒前
Lumosv完成签到,获得积分10
6秒前
猪猪侠完成签到,获得积分10
6秒前
Nora发布了新的文献求助10
7秒前
7秒前
lixiaobai发布了新的文献求助10
7秒前
秋风的应助被六六采纳,获得10
7秒前
7秒前
8秒前
8秒前
daomaihu发布了新的文献求助100
8秒前
candice0202的应助被甜美的青易采纳,获得10
8秒前
candice0202的应助被甜美的青易采纳,获得10
8秒前
candice0202的应助被甜美的青易采纳,获得10
8秒前
他山之鱼发布了新的文献求助10
8秒前
if的应助被HJJHJH采纳,获得10
8秒前
candice0202的应助被甜美的青易采纳,获得10
8秒前
华仔的应助被甜美的青易采纳,获得10
8秒前
打打的应助被甜美的青易采纳,获得10
8秒前
故意的毛豆完成签到,获得积分10
9秒前
10秒前
dfuggh完成签到,获得积分10
11秒前
oct完成签到,获得积分10
11秒前
11秒前
11秒前
精明秋柔完成签到,获得积分20
11秒前
爆米花的应助被科研通管家采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182602
求助须知:如何正确求助?哪些是违规求助? 9572033
关于积分的说明 21821767
捐赠科研通 7779061
什么是DOI,文献DOI怎么找? 3433684
关于科研通互助平台的介绍 2557863
邀请新用户注册赠送积分活动 2479732